Dr. Nancy Louise Sicotte, MD

Dr. Sicotte practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Sicotte's NPI, 1932128725, was assigned on July 19, 2006. Dr. Sicotte graduated from UC Irvine School of Medicine in 1992. Dr. Sicotte holds California license G79260.

Dr. Sicotte's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Sicotte's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Sicotte to 1 more community health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sicotte practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Sicotte's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Sicotte is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Sicotte is licensed in California.

Dmand AI lists carpal tunnel syndrome, lower back pain, migraine and chronic headache and multiple sclerosis among the conditions Dr. Sicotte treats.

CMS data shows 148 Medicare services from Dr. Sicotte across 4 procedure codes in 2024, for 119 Medicare patients. Medicare paid $10,627 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 119 Medicare patients who saw Dr. Sicotte in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high cholesterol, and 66% have arthritis. 26% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sicotte's median patient age at 60, with 69% women.

In 2024, Dr. Sicotte wrote 95 Medicare Part D claims for 32 patients. 76% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $386 in total drug cost. In 2023, CMS named 70 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Sicotte for performance year 2024, reported as part of a group. Dr. Sicotte accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sicotte as offering telehealth.

Dmand AI links 2 papers to Dr. Sicotte in 2015. Dr. Sicotte's most frequent co-authors are Tanuja Chitnis, MD, Richard Alan Lewis, MD and Mani Kalantari Nezhad, MD.

Dmand AI links Dr. Sicotte to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis and Demyelinating Autoimmune Diseases, CNS.

CMS Open Payments shows 22 general payments to Dr. Sicotte from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Novartis Pharmaceuticals Corporation paid the most, $834.

Dmand AI lists 3 awards for Dr. Sicotte, most recently Regional Top Doctor in 2014.

Dr. Sicotte graduated from UC Irvine School of Medicine in 1992.

Dr. Sicotte is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.